Prognostic value of serum thioredoxin levels in ischemic stroke

References

• Murray CJ , Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–457.
   PubMed Web of Science ®Google Scholar
• Chen H , Yoshioka H , Kim GS , et al . Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal. 2011;14:1505–1517.
   PubMed Web of Science ®Google Scholar
• Holmgren A . Thioredoxin. Annu Rev Biochem. 1985;54:237–271.
   PubMed Web of Science ®Google Scholar
• Koharyova M , Kollarova M . Thioredoxin system – a novel therapeutic target. Gen Physiol Biophys. 2015;34:221–233.
   PubMed Web of Science ®Google Scholar
• Burke-Gaffney A , Callister ME , Nakamura H . Thioredoxin: friend or foe in human disease? Trends Pharmacol Sci. 2005;26:398–404.
   PubMed Web of Science ®Google Scholar
• Mahmood DF , Abderrazak A , El Hadri K , et al . The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal. 2013;19:1266–1303.
   PubMed Web of Science ®Google Scholar
• Nakamura H , Herzenberg LA , Bai J , et al . Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA. 2001;98:15143–15148.
   PubMed Web of Science ®Google Scholar
• Ma YH , Su N , Chao XD , et al . Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative/nitrative stress. Neurochem Int. 2012;60:475–483.
   PubMed Web of Science ®Google Scholar
• Rubartelli A , Bajetto A , Allavena G , et al . Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem. 1992;267:24161–24164.
   PubMed Web of Science ®Google Scholar
• Bertini R , Howard OMZ , Dong HF , et al . Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med. 1999;189:1783–1789.
   PubMed Web of Science ®Google Scholar
• Shioji K , Kishimoto C , Nakamura H , et al . Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation. 2002;106:1403–1409.
   PubMed Web of Science ®Google Scholar
• Kasuno K , Nakamura H , Ono T , et al . Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int. 2003;64:1273–1282.
   PubMed Web of Science ®Google Scholar
• Xu J , Li T , Wu H , et al . Role of thioredoxin in lung disease. Pulm Pharmacol Ther. 2012;25:154–162.
   PubMed Web of Science ®Google Scholar
• Hattori I , Takagi Y , Nakamura H , et al . Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal. 2004;6:81–87.
   PubMed Web of Science ®Google Scholar
• Wang B , Tian S , Wang J , et al . Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke. Brain Res. 2015;1615:89–97.
   PubMed Web of Science ®Google Scholar
• Zhou F , Gomi M , Fujimoto M , et al . Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia. Brain Res. 2009;1272:62–70.
   PubMed Web of Science ®Google Scholar
• Jekell A , Hossain A , Alehagen U , et al . Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail. 2004;6:883–890.
   PubMed Web of Science ®Google Scholar
• Qi AQ , Li Y , Liu Q , et al . Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke. Free Radic Biol Med. 2015;80:129–135.
   PubMed Web of Science ®Google Scholar
• Wu MH , Song FY , Wei LP , et al . Serum levels of thioredoxin are associated with stroke risk, severity, and lesion volumes. Mol Neurobiol. 2016;53:677–685.
   PubMed Web of Science ®Google Scholar
• Pan DS , Le HW , Yan M , et al . Change of serum levels of thioredoxin in patients with severe traumatic brain injury. Clin Chim Acta. 2016;453:62–66.
   PubMed Web of Science ®Google Scholar
• Qian SQ , Hu XC , He SR , et al . Prognostic value of serum thioredoxin concentrations after intracerebral hemorrhage. Clin Chim Acta. 2016;455:15–19.
   PubMed Web of Science ®Google Scholar
• Dai JX , Cai JY , Lin Q , et al . Thioredoxin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2016;363:84–89.
   PubMed Web of Science ®Google Scholar
• Hatano S . Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–553.
   PubMed Web of Science ®Google Scholar
• Sims JR , Gharai LR , Schaefer PW , et al . ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72:2104–2110.
   PubMed Web of Science ®Google Scholar
• Brott T , Adams HP Jr , Olinger CP , et al . Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–870.
   PubMed Web of Science ®Google Scholar
• Wilterdink JL , Bendixen B , Adams HP Jr , et al . Effect of prior aspirin use on stroke severity in the trial of org 10172 in acute stroke treatment (TOAST). Stroke. 2001;32:2836–2840.
   PubMed Web of Science ®Google Scholar
• Adams HP , Bendixen BH , Kappelle LJ , et al . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
   PubMed Web of Science ®Google Scholar
• Bamford J , Sandercock P , Dennis M , et al . Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521–1526.
   PubMed Web of Science ®Google Scholar
• Qian L , Yuanshao L , Wensi H , et al . Serum IL-33 Is a novel diagnostic and prognostic biomarker in acute ischemic stroke. Aging Dis. 2016;7:614–622.
   PubMed Web of Science ®Google Scholar
• Moreno-Palacios JA , Moreno-Martinez I , Bartolome-Nogues A , et al . Prognostic factors of functional recovery from a stroke at one year. Rev Neurol. 2017;64:55–62.
   PubMed Web of Science ®Google Scholar
• Takagi Y , Gon Y , Todaka T , et al . Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries. Lab Invest. 1998;78:957–966.
   PubMed Web of Science ®Google Scholar
• Zhang H , Luo Y , Zhang W , et al . Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol. 2007;170:1108–1120.
   PubMed Web of Science ®Google Scholar
• Maulik N , Das DK . Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta. 2008;1780:1368–1382.
   PubMed Web of Science ®Google Scholar
• Ruszkiewicz J , Albrecht J . Changes of the thioredoxin system, glutathione peroxidase activity and total antioxidant capacity in rat brain cortex during acute liver failure: modulation by l-histidine. Neurochem Res. 2015;40:293–300.
   PubMed Web of Science ®Google Scholar
• Nakamura H . Thioredoxin as a key molecule in redox signaling. Antioxid Redox Signal. 2004;6:15–17.
   PubMed Web of Science ®Google Scholar
• Luna JM , Moon YP , Liu KM , et al . High-sensitivity c-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke. 2014;45:979–987.
   PubMed Web of Science ®Google Scholar
• Shimizu K , Shimomura K , Tokuyama Y , et al . Association between inflammatory biomarkers and progression of intracranial large artery stenosis after ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22:211–217.
   PubMed Web of Science ®Google Scholar
• McColl BW , Allan SM , Rothwell NJ . Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 2009;158:1049–1061.
   PubMed Web of Science ®Google Scholar
• Ormstad H , Aass HC , Lund-Sorensen N , et al . Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol. 2011;258:677–685.
   PubMed Web of Science ®Google Scholar
• Bunevicius A , Kazlauskas H , Raskauskiene N , et al . Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. Endocrine. 2014;45:213–220.
   PubMed Web of Science ®Google Scholar
• Winbeck K , Poppert H , Etgen T , et al . Prognostic relevance of early serial c-reactive protein measurements after first ischemic stroke. Stroke. 2002;33:2459–2464.
   PubMed Web of Science ®Google Scholar